Evidence map›Paper›PMID 31208390›Full record

ArticleBMC biotechnology2019

Improved CRISPR/Cas9 gene editing by fluorescence activated cell sorting of green fluorescence protein tagged protoplasts.

Bent Larsen Petersen, Svenning Rune Möller, Jozef Mravec, Bodil Jørgensen, Mikkel Christensen, Ying Liu, Hans H Wandall, Eric Paul Bennett, Zhang Yang

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Known Unknowns: An Enigmatic Pathway of CCurrent issues in molecular biology · 2025
    Review
  4. Genome editing in grain legumes for food security.Frontiers in genome editing · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. A roadmap for translational cancer glycoimmunology at single cell resolution.Journal of experimental & clinical cancer research : CR · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. First Report of CRISPR/Cas9 Mediated DNA-Free Editing ofInternational journal of molecular sciences · 2021
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 3 countries.

Bent Larsen PetersenDepartment of Plant and Environmental Sciences, University of Copenhagen, DK-1871, Frederiksberg C, Denmark. blp@plen.ku.dk.ORCID 0000-0002-2004-9077
Svenning Rune MöllerDepartment of Plant and Environmental Sciences, University of Copenhagen, DK-1871, Frederiksberg C, Denmark.
Jozef MravecDepartment of Plant and Environmental Sciences, University of Copenhagen, DK-1871, Frederiksberg C, Denmark.
Bodil JørgensenDepartment of Plant and Environmental Sciences, University of Copenhagen, DK-1871, Frederiksberg C, Denmark.
Mikkel ChristensenDepartment of Plant and Environmental Sciences, University of Copenhagen, DK-1871, Frederiksberg C, Denmark.
Ying LiuDepartment of Plant and Environmental Sciences, University of Copenhagen, DK-1871, Frederiksberg C, Denmark.
Hans H WandallCopenhagen Center for Glycomics, Department of Molecular and Cellular Medicine and School of Dentistry, Faculty of Health Sciences, University of Copenhagen, DK-2200, Copenhagen N, Denmark.
Eric Paul BennettCopenhagen Center for Glycomics, Department of Molecular and Cellular Medicine and School of Dentistry, Faculty of Health Sciences, University of Copenhagen, DK-2200, Copenhagen N, Denmark.
Zhang YangCopenhagen Center for Glycomics, Department of Molecular and Cellular Medicine and School of Dentistry, Faculty of Health Sciences, University of Copenhagen, DK-2200, Copenhagen N, Denmark.
University of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCRISPR/Cas9 is widely used for precise genetic editing in various organisms. CRISPR/Cas9 editing may in many plants be hampered by the presence of complex and high ploidy genomes and inefficient or poorly controlled delivery of the CRISPR/Cas9 components to gamete cells or cells with regenerative potential. Optimized strategies and methods to overcome these challenges are therefore in demand.

resultsIn this study we investigated the feasibility of improving CRISPR/Cas9 editing efficiency by Fluorescence Activated Cell Sorting (FACS) of protoplasts. We used Agrobacterium infiltration in leaves of Nicotiana benthamiana for delivery of viral replicons for high level expression of gRNAs designed to target two loci in the genome, NbPDS and NbRRA, together with the Cas9 nuclease in fusion with the 2A self-splicing sequence and GFP (Cas9-2A-GFP). Protoplasts isolated from the infiltrated leaves were then subjected to FACS for selection of GFP enriched protoplast populations. This procedure resulted in a 3-5 fold (from 20 to 30% in unsorted to more than 80% in sorted) increase in mutation frequencies as evidenced by restriction enzyme analysis and the Indel Detection by Amplicon Analysis, which allows for high throughput profiling and quantification of the generated mutations.

conclusionsFACS of protoplasts expressing GFP tagged CRISPR/Cas9, delivered through A. tumefaciens leaf infiltration, facilitated clear CRISPR/Cas9 mediated mutation enrichment in selected protoplast populations.

Indexed as

CRISPR-Cas SystemsFlow CytometryFluorescenceGene EditingGreen Fluorescent ProteinsMicroscopy, FluorescenceMutationNicotianaPlant LeavesPlants, Genetically ModifiedProtoplastsGreen Fluorescent ProteinsCRISPR/Cas9Fluorescence activated cell sortingGenome engineeringMutation enrichmentNicotiana benthamianaPrecise genetic editingProtoplasting

Identifiers

PMID31208390
PMCPMC6580576
OpenAlexW2949285307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.